Adjuvant Iodine(131) Lipiodol after Resection of Hepatocellular Carcinoma

Background. Survival after liver resection for HCC is compromised by a high rate of intrahepatic recurrence. Adjuvant treatment with a single, postoperative dose of intra-arterial I(131) lipiodol has shown promise, as a means of prolonging disease-free survival (DFS). Methodology. DFS and overall su...

Descripción completa

Detalles Bibliográficos
Autores principales: Furtado, Ruelan V., Ha, Leo, Clarke, Stephen, Sandroussi, Charbel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680111/
https://www.ncbi.nlm.nih.gov/pubmed/26713092
http://dx.doi.org/10.1155/2015/746917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680111/
https://www.ncbi.nlm.nih.gov/pubmed/26713092
http://dx.doi.org/10.1155/2015/746917

Ejemplares similares